Milestone Pharmaceuticals Inc. Increase (Decrease) in Prepaid Expense
Milestone Pharmaceuticals Inc. (MIST) reported Increase (Decrease) in Prepaid Expense of -$770.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-12
- Milestone Pharmaceuticals Inc. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was -$175.00K.
- Milestone Pharmaceuticals Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was -$595.00K, a 215.31% decline year-over-year.
- Milestone Pharmaceuticals Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$766.00K.
- Milestone Pharmaceuticals Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was $1.83M, a 125.80% increase year-over-year.
- Milestone Pharmaceuticals Inc. increase (decrease) in prepaid expense for fiscal 2025 was -$29.00K.
- Milestone Pharmaceuticals Inc. increase (decrease) in prepaid expense for fiscal 2024 was -$1.34M.
- Milestone Pharmaceuticals Inc. increase (decrease) in prepaid expense for fiscal 2023 was -$2.83M, a 265.71% decline from fiscal 2022.
- Milestone Pharmaceuticals Inc. increase (decrease) in prepaid expense for fiscal 2022 was $1.71M.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$770.00K 10-Q · filed 2026-08-12 | -$1.54M derived: sum of 3 quarters · filed 2026-08-12 | $293.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$595.00K 10-Q · filed 2026-05-13 | -$1.36M derived: sum of 2 quarters · filed 2026-05-13 | $468.00K derived: sum of 3 quarters · filed 2026-05-13 | -$1.14M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$766.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $1.06M derived: sum of 2 quarters · filed 2026-03-20 | -$545.00K derived: sum of 3 quarters · filed 2026-08-12 | -$29.00K 10-K · filed 2026-03-20 |
| 2025-09-30 | $1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $221.00K derived: sum of 2 quarters · filed 2026-08-12 | $737.00K 10-Q · filed 2025-11-12 | $54.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$1.09M 10-Q · filed 2026-08-12 | -$1.77M derived: sum of 3 quarters · filed 2026-08-12 | -$965.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $516.00K 10-Q · filed 2026-05-13 | -$167.00K derived: sum of 2 quarters · filed 2026-05-13 | $643.00K derived: sum of 3 quarters · filed 2026-05-13 | -$6.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$683.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $127.00K derived: sum of 2 quarters · filed 2026-03-20 | -$522.00K derived: sum of 3 quarters · filed 2026-03-20 | -$1.34M 10-K · filed 2026-03-20 |
| 2024-09-30 | $810.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $161.00K derived: sum of 2 quarters · filed 2025-11-12 | -$655.00K 10-Q · filed 2025-11-12 | -$4.44M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$649.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.47M 10-Q · filed 2025-08-12 | -$5.25M derived: sum of 3 quarters · filed 2025-08-12 | -$3.69M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$816.00K 10-Q · filed 2025-05-14 | -$4.60M derived: sum of 2 quarters · filed 2025-05-14 | -$3.04M derived: sum of 3 quarters · filed 2025-05-14 | -$3.08M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$2.22M derived: sum of 2 quarters · filed 2025-03-13 | -$2.27M derived: sum of 3 quarters · filed 2025-03-13 | -$2.83M 10-K · filed 2025-03-13 |
| 2023-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.51M derived: sum of 2 quarters · filed 2024-11-12 | $956.00K 10-Q · filed 2024-11-12 | $1.90M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$605.00K 10-Q · filed 2024-08-08 | $342.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.94M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$558.00K 10-Q · filed 2024-05-13 | $389.00K derived: sum of 2 quarters · filed 2024-05-13 | $1.98M derived: sum of 3 quarters · filed 2024-05-13 | $1.38M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $947.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $2.54M derived: sum of 2 quarters · filed 2024-03-21 | $1.94M derived: sum of 3 quarters · filed 2024-03-21 | $1.71M 10-K · filed 2024-03-21 |
| 2022-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $990.00K derived: sum of 2 quarters · filed 2023-11-13 | $759.00K 10-Q · filed 2023-11-13 | -$910.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$603.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$834.00K 10-Q · filed 2023-08-10 | -$2.50M derived: sum of 3 quarters · filed 2023-08-10 | -$3.98M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$231.00K 10-Q · filed 2023-05-11 | -$1.90M derived: sum of 2 quarters · filed 2023-05-11 | -$3.38M derived: sum of 3 quarters · filed 2023-05-11 | -$2.22M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$3.15M derived: sum of 2 quarters · filed 2023-03-29 | -$1.99M derived: sum of 3 quarters · filed 2023-03-29 | -$1.13M 10-K · filed 2023-03-29 |
| 2021-09-30 | -$1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$324.00K derived: sum of 2 quarters · filed 2022-11-10 | $540.00K 10-Q · filed 2022-11-10 | $2.46M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $2.02M 10-Q · filed 2022-08-10 | $3.94M derived: sum of 3 quarters · filed 2022-08-10 | $1.31M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $864.00K 10-Q · filed 2022-05-12 | $2.79M derived: sum of 2 quarters · filed 2022-05-12 | $160.00K derived: sum of 3 quarters · filed 2022-05-12 | $4.73M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$704.00K derived: sum of 2 quarters · filed 2022-03-24 | $3.86M derived: sum of 3 quarters · filed 2022-03-24 | $3.58M 10-K · filed 2022-03-24 |
| 2020-09-30 | -$2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.94M derived: sum of 2 quarters · filed 2021-11-12 | $1.66M 10-Q · filed 2021-11-12 | -$13.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $4.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $4.29M 10-Q · filed 2021-08-11 | $2.62M derived: sum of 3 quarters · filed 2021-08-11 | $1.10M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$280.00K 10-Q · filed 2021-05-17 | -$1.95M derived: sum of 2 quarters · filed 2021-05-17 | -$3.47M derived: sum of 3 quarters · filed 2021-05-17 | -$3.93M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$3.19M derived: sum of 2 quarters · filed 2021-03-29 | -$3.65M derived: sum of 3 quarters · filed 2021-03-29 | $447.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | -$1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$1.98M derived: sum of 2 quarters · filed 2020-11-13 | $2.12M 10-Q · filed 2020-11-13 | $2.05M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | -$466.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $3.63M 10-Q · filed 2020-08-12 | $3.56M derived: sum of 3 quarters · filed 2020-10-23 | $4.59M derived: sum of 4 quarters · filed 2020-10-23 |
| 2019-03-31 | $4.10M 10-Q · filed 2020-05-14 | $4.03M derived: sum of 2 quarters · filed 2020-10-23 | $5.05M derived: sum of 3 quarters · filed 2020-10-23 | $4.75M derived: sum of 4 quarters · filed 2020-10-23 |
| 2018-12-31 | -$71.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-10-23 | $955.00K derived: sum of 2 quarters · filed 2020-10-23 | $654.00K derived: sum of 3 quarters · filed 2020-10-23 | $1.30M 10-K/A · filed 2020-10-23 |
| 2018-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $725.00K derived: sum of 2 quarters · filed 2019-11-13 | $1.37M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $343.00K 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $644.00K 10-Q · filed 2019-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |